Wendelboe A. J.I. Weitz 2024 Global Health Burden of venous thromboembolism. Arterioscler Thromb Vasc Biol 44 5 1007–11.

Article  CAS  PubMed  Google Scholar 

Liederman Z, Chan N, Bhagirath V. Curr Challenges Diagnosis Venous Thromboembolism J Clin Med, 2020. 9(11).

Yang P, et al. [Pyr(1)]Apelin-13((1–12)) is a biologically active ACE2 metabolite of the endogenous Cardiovascular peptide [Pyr(1)]Apelin-13. Front Neurosci. 2017;11:92.

Article  PubMed  PubMed Central  Google Scholar 

Sun X, et al. Impact of Apelin-13 on the development of coronary artery Ectasia. Acta Cardiol Sin. 2020;36(3):216–22.

PubMed  PubMed Central  Google Scholar 

Mehrban A, et al. Evaluation of elevated serum apelin-13 and D-dimer concentrations in individuals diagnosed with pulmonary embolism. Int J Emerg Med. 2024;17(1):48.

Article  PubMed  PubMed Central  Google Scholar 

Arnold MJ. Thromboembolic Disease. Prim Care. 2024;51(1):65–82.

Article  PubMed  Google Scholar 

McManus RJ et al. Thromboembolism. BMJ Clin Evid, 2011. 2011.

Klemen ND, et al. Mortality risk associated with venous thromboembolism: a systematic review and bayesian meta-analysis. Lancet Haematol. 2020;7(8):e583–93.

Article  PubMed  Google Scholar 

General OotS, National Heart L, Institute B. The Surgeon General’s call to action to prevent deep vein thrombosis and pulmonary embolism. 2008.

Sidney S, et al. Age-adjusted mortality rates and age and risk–associated contributions to change in heart disease and stroke mortality, 2011–2019 and 2019–2020. JAMA Netw open. 2022;5(3):pe223872–e223872.

Article  Google Scholar 

Grande Ratti MF, et al. Incidence of hospital-acquired venous thromboembolic disease. Rev Fac Cien Med Univ Nac Cordoba. 2018;75(2):82–7.

Article  PubMed  Google Scholar 

Lutsey PL, Zakai NA. Epidemiology and prevention of venous thromboembolism. Nat Reviews Cardiol. 2023;20(4):248–62.

Article  Google Scholar 

Virani SS et al. Heart disease and stroke statistics-2021 update: a report from the American Heart Association. 2021.

Wendelboe AM, Raskob GE. Global burden of thrombosis: epidemiologic aspects. Circul Res. 2016;118(9):1340–7.

Article  CAS  Google Scholar 

Bell EJ, et al. Lifetime risk of venous thromboembolism in two cohort studies. Am J Med. 2016;129(3):339. e19-339. e26.

Article  Google Scholar 

Watson C, et al. Venous thromboembolism: review of Clinical challenges, Biology, Assessment, Treatment, and modeling. Ann Biomed Eng. 2024;52(3):467–86.

Article  PubMed  Google Scholar 

Kushner A, et al. Virchow triad, in StatPearls [Internet]. StatPearls Publishing; 2022.

Google Scholar 

Saha P, et al. Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions. Arterioscler Thromb Vasc Biol. 2011;31(3):506–12.

Article  CAS  PubMed  Google Scholar 

Piazza G. Beyond Virchow’s Triad: does cardiovascular inflammation explain the recurrent nature of venous thromboembolism? London, England: SAGE Publications Sage UK; 2015. pp. 102–4.

Google Scholar 

Smith SA, Travers RJ, Morrissey JH. How it all starts: initiation of the clotting cascade. Crit Rev Biochem Mol Biol. 2015;50(4):326–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alias S, Lang IM. Coagulation and the vessel wall in pulmonary embolism. Pulm Circ. 2013;3(4):728–38.

Article  PubMed  PubMed Central  Google Scholar 

Martinelli I, et al. Risk of venous thromboembolism after air travel: interaction with thrombophilia and oral contraceptives. Arch Intern Med. 2003;163(22):2771–4.

Article  PubMed  Google Scholar 

Parkin L, et al. Air travel and fatal pulmonary embolism. Thromb Haemost. 2006;95(05):807–14.

Article  CAS  PubMed  Google Scholar 

Rogers MA, et al. Triggers of hospitalization for venous thromboembolism. Circulation. 2012;125(17):2092–9.

Article  PubMed  PubMed Central  Google Scholar 

Konstantinides SV, et al. The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): the Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J. 2019;54(3):1901647.

Article  PubMed  Google Scholar 

White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003;90(09):446–55.

Article  CAS  PubMed  Google Scholar 

Horner D, et al. Individual risk factors predictive of venous thromboembolism in patients with temporary lower limb immobilization due to injury: a systematic review. J Thromb Haemost. 2019;17(2):329–44.

Article  PubMed  PubMed Central  Google Scholar 

Mahmoud SS, Esser M, Jain A. Thromboembolic events in pelvic and acetabulum fractures: a systematic review of the current literature on incidence, screening, and thromboprophylaxis. Int Orthop. 2022;46(8):1707–20.

Article  PubMed  Google Scholar 

Ma J, et al. Incidence and risk factors of preoperative deep venous thrombosis in closed tibial shaft fracture: a prospective cohort study. Archives of Orthopaedic and Trauma Surgery; 2020. pp. 1–7.

Google Scholar 

Cosmi B, et al. Sex, age and normal post-anticoagulation D‐dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension. J Thromb Haemost. 2010;8(9):1933–42.

Article  CAS  PubMed  Google Scholar 

Akrivou D, et al. Pathophysiological aspects of aging in venous thromboembolism: an update. Medicina. 2022;58(8):1078.

Article  PubMed  PubMed Central  Google Scholar 

Borch K, et al. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromsø study. J Thromb Haemost. 2009;7(5):739–45.

Article  CAS  PubMed  Google Scholar 

Puurunen MK, et al. Epidemiology of venous thromboembolism in the Framingham Heart Study. Thromb Res. 2016;145:27–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mi Y, et al. Venous thromboembolism has the same risk factors as atherosclerosis: a PRISMA-compliant systemic review and meta-analysis. Medicine. 2016;95(32):e4495.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bertina RM, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369(6475):64–7.

Article  CAS  PubMed  Google Scholar 

Poort SR et al. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. 1996.

Zhang Q et al. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism–a meta-analysis and systematic review. Vasa, 2020.

Bai J, et al. Diabetes is associated with increased risk of venous thromboembolism: a systematic review and meta-analysis. Thromb Res. 2015;135(1):90–5.

Agnelli G, et al. Apixaban versus dalteparin for the treatment of acute venous thromboembolism in patients with cancer: the Caravaggio study. Thromb Haemost. 2018;118(09):1668–78.

Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome. N Engl J Med. 2018;378(21):2010–21.

Bucci T, et al. Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study. Thromb Res. 2022;209:69–74.

Article  CAS  PubMed  Google Scholar 

Abou-Ismail MY, Sridhar DC, Nayak L. Estrogen and thrombosis: a bench to bedside review. Thromb Res. 2020;192:40–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

de Bastos M et al. Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Reviews, 2014(3).

Ahlehoff O, et al. Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: a Danish nationwide cohort study. Lupus. 2017;26(13):1435–9.

Article